Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
出版年份 2015 全文链接
标题
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium
作者
关键词
Next-generation sequencing, Semi-conductor sequencing, Colorectal cancer, Non-small cell lung cancer, Multiplex PCR, Ion Torrent
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-01-30
DOI
10.1186/s12885-015-1015-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
- (2013) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomics-Driven Oncology: Framework for an Emerging Paradigm
- (2013) Levi A. Garraway JOURNAL OF CLINICAL ONCOLOGY
- Personalizing Oncology: Perspectives and Prospects
- (2013) John Mendelsohn JOURNAL OF CLINICAL ONCOLOGY
- Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies
- (2013) Tianhong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
- (2013) Julien Mazières et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach
- (2013) Volker Endris et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
- (2013) Andrew G. Hadd et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Activity of Gefitinib in a Non–Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations
- (2013) Alessandro Morabito et al. Journal of Thoracic Oncology
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas
- (2012) M. E. Arcila et al. CLINICAL CANCER RESEARCH
- A combined oncogenic pathway signature ofBRAF,KRASandPI3KCAmutation improves colorectal cancer classification and cetuximab treatment prediction
- (2012) Sun Tian et al. GUT
- Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
- (2012) Nicola Normanno et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping
- (2012) Carol Beadling et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu
- (2012) J. De Grève et al. LUNG CANCER
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Qing Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Quantitative Analysis of Tumor in Bronchial Biopsy Specimens
- (2010) Caroline L. Coghlin et al. Journal of Thoracic Oncology
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
- (2008) Elizabeth Day et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started